respond healthcare limited
respond healthcare limited Company Information
Company Number
NI629409
Website
www.respond.co.ukRegistered Address
kathleen drive 15, ballystockart road, newtownards, county down, BT23 5QY
Industry
Wholesale of pharmaceutical goods
Telephone
08000286848
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
eakin healthcare group limited 100%
respond healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of RESPOND HEALTHCARE LIMITED at £53.7m based on a Turnover of £43.3m and 1.24x industry multiple (adjusted for size and gross margin).
respond healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of RESPOND HEALTHCARE LIMITED at £34.6m based on an EBITDA of £3.6m and a 9.73x industry multiple (adjusted for size and gross margin).
respond healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of RESPOND HEALTHCARE LIMITED at £51.5m based on Net Assets of £24.5m and 2.11x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Respond Healthcare Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Respond Healthcare Limited Overview
Respond Healthcare Limited is a live company located in newtownards, BT23 5QY with a Companies House number of NI629409. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in February 2015, it's largest shareholder is eakin healthcare group limited with a 100% stake. Respond Healthcare Limited is a young, large sized company, Pomanda has estimated its turnover at £43.3m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Respond Healthcare Limited Health Check
Pomanda's financial health check has awarded Respond Healthcare Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 1 areas for improvement. Company Health Check FAQs
7 Strong
4 Regular
1 Weak
Size
annual sales of £43.3m, make it larger than the average company (£25.5m)
£43.3m - Respond Healthcare Limited
£25.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (4.9%)
9% - Respond Healthcare Limited
4.9% - Industry AVG
Production
with a gross margin of 24.8%, this company has a comparable cost of product (23.7%)
24.8% - Respond Healthcare Limited
23.7% - Industry AVG
Profitability
an operating margin of 7% make it more profitable than the average company (3.6%)
7% - Respond Healthcare Limited
3.6% - Industry AVG
Employees
with 108 employees, this is above the industry average (37)
108 - Respond Healthcare Limited
37 - Industry AVG
Pay Structure
on an average salary of £32.7k, the company has a lower pay structure (£66.5k)
£32.7k - Respond Healthcare Limited
£66.5k - Industry AVG
Efficiency
resulting in sales per employee of £401.2k, this is less efficient (£636.8k)
£401.2k - Respond Healthcare Limited
£636.8k - Industry AVG
Debtor Days
it gets paid by customers after 66 days, this is near the average (61 days)
66 days - Respond Healthcare Limited
61 days - Industry AVG
Creditor Days
its suppliers are paid after 35 days, this is close to average (33 days)
35 days - Respond Healthcare Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 44 days, this is less than average (58 days)
44 days - Respond Healthcare Limited
58 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 8 weeks, this is average cash available to meet short term requirements (9 weeks)
8 weeks - Respond Healthcare Limited
9 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 17%, this is a lower level of debt than the average (56.5%)
17% - Respond Healthcare Limited
56.5% - Industry AVG
respond healthcare limited Credit Report and Business Information
Respond Healthcare Limited Competitor Analysis
Perform a competitor analysis for respond healthcare limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
respond healthcare limited Ownership
RESPOND HEALTHCARE LIMITED group structure
Respond Healthcare Limited has 3 subsidiary companies.
Ultimate parent company
DUNROGAN LTD
#0125694
2 parents
RESPOND HEALTHCARE LIMITED
NI629409
3 subsidiaries
respond healthcare limited directors
Respond Healthcare Limited currently has 3 directors. The longest serving directors include Mr Owen Tiernan (Jun 2021) and Mr Owen Tiernan (Jun 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Owen Tiernan | Wales | 49 years | Jun 2021 | - | Director |
| Mr Owen Tiernan | Wales | 49 years | Jun 2021 | - | Director |
| Mr Padraic Dempsey | Wales | 46 years | Oct 2023 | - | Director |
RESPOND HEALTHCARE LIMITED financials
Respond Healthcare Limited's latest turnover from March 2023 is £43.3 million and the company has net assets of £24.5 million. According to their latest financial statements, Respond Healthcare Limited has 108 employees and maintains cash reserves of £832.4 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 43,329,566 | 38,721,741 | 34,196,244 | 33,546,204 | 29,917,278 | 27,995,009 | 26,627,306 | 12,555,611 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 32,594,217 | 28,376,837 | 23,987,254 | 23,368,310 | 20,766,642 | 19,277,162 | 18,120,518 | 8,658,005 |
| Gross Profit | 10,735,349 | 10,344,904 | 10,208,990 | 10,177,894 | 9,150,636 | 8,717,847 | 8,506,788 | 3,897,606 |
| Admin Expenses | 7,687,932 | 7,530,018 | 7,800,405 | 8,262,242 | 7,158,765 | 6,591,430 | 6,097,386 | -6,517,173 |
| Operating Profit | 3,047,417 | 2,814,886 | 2,408,585 | 1,915,652 | 1,991,871 | 2,126,417 | 2,409,402 | 10,414,779 |
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 63,889 | 7,000 | 16,283 | 11,329 | 0 | 486 | 60 | 484 |
| Pre-Tax Profit | 3,111,306 | 2,821,886 | 2,424,868 | 1,926,981 | 1,991,871 | 2,126,903 | 2,409,462 | 10,415,263 |
| Tax | -522,209 | -108,186 | -491,012 | -388,242 | -423,634 | -412,376 | -509,855 | -9,131 |
| Profit After Tax | 2,589,097 | 2,713,700 | 1,933,856 | 1,538,739 | 1,568,237 | 1,714,527 | 1,899,607 | 10,406,132 |
| Dividends Paid | 4,000,000 | 2,500,000 | 1,000,000 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -1,410,903 | 213,700 | 933,856 | 1,538,739 | 1,568,237 | 1,714,527 | 1,899,607 | 10,406,132 |
| Employee Costs | 3,531,209 | 3,637,620 | 3,248,387 | 3,540,337 | 3,180,433 | 3,030,903 | 3,252,620 | 1,468,413 |
| Number Of Employees | 108 | 106 | 102 | 99 | 100 | 99 | 99 | 84 |
| EBITDA* | 3,556,979 | 3,460,394 | 3,051,407 | 2,568,472 | 2,466,948 | 2,733,581 | 2,971,036 | 10,690,746 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 3,588,872 | 3,746,390 | 3,785,053 | 3,889,818 | 3,744,939 | 3,843,089 | 3,439,657 | 1,699,969 |
| Intangible Assets | 13,046,531 | 13,361,697 | 13,800,619 | 14,239,541 | 14,691,510 | 15,130,702 | 15,569,513 | 15,995,268 |
| Investments & Other | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 100,002 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 16,635,405 | 17,108,089 | 17,585,674 | 18,129,361 | 18,436,451 | 18,973,793 | 19,009,172 | 17,795,239 |
| Stock & work in progress | 3,936,564 | 3,295,884 | 3,273,416 | 2,880,660 | 2,426,110 | 2,147,424 | 1,897,002 | 1,673,561 |
| Trade Debtors | 7,881,951 | 7,373,985 | 6,126,112 | 6,608,153 | 5,547,797 | 5,111,443 | 4,740,314 | 4,391,256 |
| Group Debtors | 19,014 | 46,526 | 2,193 | 95,647 | 87,130 | 10,167 | 19 | 44,194 |
| Misc Debtors | 184,739 | 640,614 | 180,041 | 138,343 | 97,786 | 77,982 | 282,380 | 422,212 |
| Cash | 832,408 | 1,485,394 | 2,429,708 | 2,226,021 | 1,890,338 | 924,970 | 1,074,346 | 107,989 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 12,854,676 | 12,842,403 | 12,011,470 | 11,948,824 | 10,049,161 | 8,271,986 | 7,994,061 | 6,639,212 |
| total assets | 29,490,081 | 29,950,492 | 29,597,144 | 30,078,185 | 28,485,612 | 27,245,779 | 27,003,233 | 24,434,451 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 140,282 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 3,184,257 | 2,394,194 | 2,172,067 | 2,457,767 | 1,767,613 | 1,547,683 | 1,396,886 | 1,693,385 |
| Group/Directors Accounts | 1,093,284 | 669,190 | 695,705 | 1,228,681 | 2,637,784 | 3,230,815 | 5,011,053 | 4,016,889 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 635,272 | 908,662 | 1,008,580 | 1,616,797 | 845,581 | 814,267 | 673,450 | 571,334 |
| total current liabilities | 4,912,813 | 3,972,046 | 3,876,352 | 5,303,245 | 5,250,978 | 5,592,765 | 7,081,389 | 6,421,890 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 113,372 | 103,647 | 59,693 | 47,697 | 46,130 | 32,747 | 16,104 | 6,428 |
| total long term liabilities | 113,372 | 103,647 | 59,693 | 47,697 | 46,130 | 32,747 | 16,104 | 6,428 |
| total liabilities | 5,026,185 | 4,075,693 | 3,936,045 | 5,350,942 | 5,297,108 | 5,625,512 | 7,097,493 | 6,428,318 |
| net assets | 24,463,896 | 25,874,799 | 25,661,099 | 24,727,243 | 23,188,504 | 21,620,267 | 19,905,740 | 18,006,133 |
| total shareholders funds | 24,463,896 | 25,874,799 | 25,661,099 | 24,727,243 | 23,188,504 | 21,620,267 | 19,905,740 | 18,006,133 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Operating Profit | 3,047,417 | 2,814,886 | 2,408,585 | 1,915,652 | 1,991,871 | 2,126,417 | 2,409,402 | 10,414,779 |
| Depreciation | 194,396 | 206,586 | 203,900 | 212,670 | 35,285 | 167,213 | 122,710 | 56,505 |
| Amortisation | 315,166 | 438,922 | 438,922 | 440,150 | 439,792 | 439,951 | 438,924 | 219,462 |
| Tax | -522,209 | -108,186 | -491,012 | -388,242 | -423,634 | -412,376 | -509,855 | -9,131 |
| Stock | 640,680 | 22,468 | 392,756 | 454,550 | 278,686 | 250,422 | 223,441 | 1,673,561 |
| Debtors | 24,579 | 1,752,779 | -533,797 | 1,109,430 | 533,121 | 176,879 | 165,051 | 4,857,662 |
| Creditors | 790,063 | 222,127 | -285,700 | 690,154 | 219,930 | 150,797 | -296,499 | 1,693,385 |
| Accruals and Deferred Income | -273,390 | -99,918 | -608,217 | 771,216 | 31,314 | 140,817 | 102,116 | 571,334 |
| Deferred Taxes & Provisions | 9,725 | 43,954 | 11,996 | 1,567 | 13,383 | 16,643 | 9,676 | 6,428 |
| Cash flow from operations | 2,895,909 | 1,743,124 | 1,819,515 | 2,079,187 | 1,496,134 | 2,202,161 | 1,887,982 | 6,421,539 |
| Investing Activities | ||||||||
| capital expenditure | 0 | 0 | 0 | 0 | -124,516 | -572,135 | -1,935,430 | -18,071,207 |
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | -100,000 | 100,002 |
| cash flow from investments | 0 | 0 | 0 | 0 | -124,516 | -572,135 | -1,835,430 | -18,171,209 |
| Financing Activities | ||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 424,094 | -26,515 | -532,976 | -1,409,103 | -593,031 | -1,780,238 | 994,164 | 4,016,889 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||
| interest | 63,889 | 7,000 | 16,283 | 11,329 | 0 | 486 | 60 | 484 |
| cash flow from financing | 487,983 | -19,515 | -516,693 | -1,397,774 | -593,031 | -1,779,752 | 994,224 | 11,617,374 |
| cash and cash equivalents | ||||||||
| cash | -652,986 | -944,314 | 203,687 | 335,683 | 965,368 | -149,376 | 966,357 | 107,989 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | -140,282 | 140,282 |
| change in cash | -652,986 | -944,314 | 203,687 | 335,683 | 965,368 | -149,376 | 1,106,639 | -32,293 |
P&L
March 2023turnover
43.3m
+12%
operating profit
3m
+8%
gross margin
24.8%
-7.26%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
24.5m
-0.05%
total assets
29.5m
-0.02%
cash
832.4k
-0.44%
net assets
Total assets minus all liabilities
respond healthcare limited company details
company number
NI629409
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
February 2015
age
9
accounts
Full Accounts
ultimate parent company
previous names
respond plus healthcare limited (September 2015)
incorporated
UK
address
kathleen drive 15, ballystockart road, newtownards, county down, BT23 5QY
last accounts submitted
March 2023
respond healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to respond healthcare limited.
respond healthcare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
